Key result
Propafenone treatment in children with tachyarrhythmias demonstrated an overall efficacy of 76% for acute and 69% for chronic treatment, with side effects observed in 25% of patients.
Why the study?
Does propafenone improve outcomes in children with tachyarrhythmias?
Population
60 children with tachyarrhythmias including paroxysmal re-entrant supraventricular tachycardia…
Design
Case_series
Authors
Loading...
May support propafenone consideration in pediatric tachyarrhythmias with monitoring; leaves open need for controlled trials to confirm outcomes.
Observational (n=60)
Does propafenone improve outcomes in children with tachyarrhythmias?
Propafenone is an effective and relatively safe treatment for various tachyarrhythmias in children, particularly paroxysmal rSVT, though careful ECG monitoring is required initially due to potential toxic levels.
Vignati et al. (1993) conducted an observational in Tachyarrhythmias (n=60). Propafenone was evaluated on Overall efficacy for acute treatment. Propafenone treatment in children with tachyarrhythmias demonstrated an overall efficacy of 76% for acute and 69% for chronic treatment, with side effects observed in 25% of patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: